Evidence map›Paper›PMID 34983975›Full record

ArticleJournal of human genetics2022

Biallelic loss of TRAPPC9 function links vesicle trafficking pathway to autosomal recessive intellectual disability.

Ayca Dilruba Aslanger, Beyza Goncu, Omer Faruk Duzenli, Emrah Yucesan, Esma Sengenc, Gozde Yesil

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Genes · 2026
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Molecular syndromology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Variable allelic expression of imprinted genes at theFrontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ayca Dilruba Aslanger *Department of Medical Genetics, Faculty of Medicine, Istanbul University, Istanbul, Turkey. aaslanger@yahoo.com.ORCID http://orcid.org/0000-0003-1770-1762
Beyza Goncu *Experimental Research Center, Bezmialem Vakıf University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-6026-8218
Omer Faruk DuzenliExperimental Research Center, Bezmialem Vakıf University, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-2938-711X
Emrah YucesanDepartment of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Esma SengencDepartment of Pediatric Neurology, Faculty of Medicine, Bezmialem Vakıf University, Istanbul, Turkey.
Gozde YesilDepartment of Medical Genetics, Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Bezmiâlem Vakıf Üniversitesi · TRIstanbul University · TR

Funding

Bezmiâlem Vakif Üniversitesi (Bezmialem Vakif University) 42019/20
6 · The paper itself

Abstract

backgroundThe trafficking protein particle (TRAPP) complex subunit 9 (C9) protein is a member of TRAPP-II complexes and regulates vesicle trafficking. Biallelic mutations in the TRAPPC9 gene are responsible for intellectual disability with expanded developmental delay, epilepsy, microcephaly, and brain atrophy. TRAPPC9-related disease list is still expanding, however, the functional effects of only a limited fraction of these have been studied.

methodsIn a patient with a pathological variant in TRAPPC9, clinical examination and cranial imaging findings were evaluated. Whole-exome sequencing, followed by Sanger sequencing was performed to detect and verify the variant. To confirm the functional effect of the mutation; variant mRNA and protein expression levels were evaluated by qRT-PCR and Western blotting. Immunostaining for TRAPPC9 and lipid droplet accumulation were examined.

resultsWe have identified a novel homozygous c.696C>G (p.Phe232Leu) pathogenic variant in TRAPPC9 (NM_031466.6) gene as a cause of severe developmental delay. Functional characterization of the TRAPPC9 variant resulted in decreased mRNA and protein expression. The intracellular findings showed that TRAPPC9 protein build-up around the nucleus in mutant type while there was no specific accumulation in the control cell line. This disrupted protein pattern affected the amount of neutral lipid-carrying vesicles and their homogenous distribution at a decreasing level.

conclusionBiallelic variants in the TRAPPC9 gene have been reported as the underlying cause of intellectual disability. This study provides functional evidence of the novel variant in TRAPPC9 We demonstrated that the loss of function variant exclusively targeting TRAPPC9 may explicate the neurological findings through vesicle trafficking.

Indexed as

Intellectual DisabilityMicrocephalyNervous System MalformationsHomozygoteHumansIntercellular Signaling Peptides and ProteinsPedigreeRNA, MessengerIntercellular Signaling Peptides and ProteinsRNA, Messenger

Identifiers

PMID34983975
OpenAlexW4205991080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.